Interrogating the tumor microenvironment (TME) in patients (pts) with head and neck mucosal squamous cell carcinoma (HNmSCC) treated with programmed death-1 (PD-1) inhibitors

被引:0
|
作者
Ferguson, Angela L.
Beddow, Thomas
Patrick, Ellis
Willie, Elijah
Elliott, Michael
Low, Tsu-Hui
Wykes, James
Palme, Carsten
Clark, Jonathan
Hui, Mun Ngah
Palendira, Umaimainthan
Gupta, Ruta
Lee, Jenny H. J.
机构
[1] Univ Sydney, Centenary Inst, Sydney, NSW, Australia
[2] Univ Sydney, Sydney, NSW, Australia
[3] Chris OBrien Lifehouse, Sydney, NSW, Australia
[4] Chris OBrien Lifehouse, Camperdown, NSW, Australia
[5] NSW Hlth Pathol, Sydney, NSW, Australia
基金
澳大利亚国家健康与医学研究理事会;
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
6048
引用
收藏
页数:1
相关论文
共 50 条
  • [41] Expression of PD-1/PD-L1 in head and neck squamous cell carcinoma and its clinical significance
    Chen, Shu-Wei
    Li, Si-Hao
    Shi, Ding-Bo
    Jiang, Wen-Mei
    Song, Ming
    Yang, An-Kui
    Li, Yu-Dong
    Bei, Jin-Xin
    Chen, Wen-Kuan
    Zhang, Quan
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2019, 34 (04): : 398 - 405
  • [42] Stratification of ovarian tumor pathology by expression of programmed cell death-1 (PD-1) and PD-ligand- 1 (PD-L1) in ovarian cancer
    Maureen L. Drakes
    Swati Mehrotra
    Monica Aldulescu
    Ronald K. Potkul
    Yueying Liu
    Anne Grisoli
    Cara Joyce
    Timothy E. O’Brien
    M. Sharon Stack
    Patrick J. Stiff
    Journal of Ovarian Research, 11
  • [43] Stratification of ovarian tumor pathology by expression of programmed cell death-1 (PD-1) and PD-ligand-1 (PD-L1) in ovarian cancer
    Drakes, Maureen L.
    Mehrotra, Swati
    Aldulescu, Monica
    Potkul, Ronald K.
    Liu, Yueying
    Grisoli, Anne
    Joyce, Cara
    O'Brien, Timothy E.
    Stack, M. Sharon
    Stiff, Patrick J.
    JOURNAL OF OVARIAN RESEARCH, 2018, 11
  • [44] Programmed cell death-1 receptor (PD-1) mediated regulation of Tbet+ innate lymphoid cells within the tumour microenvironment
    Lim, Jing Xuan
    Lai, Chester
    Mallett, Grace
    Mcdonald, David
    Hulme, Gillian
    Hussain, Rafiqul
    Scott, Arron
    Laba, Stephanie
    Payne, Megan
    Patterson, Warren
    Alexander, Michael
    Ojeda-Garcia, Juan
    Coxhead, Jonathan
    Filby, Andrew
    Plummer, Ruth
    Lovat, Penny
    Healy, Eugene
    Amarnath, Shoba
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 186 (06) : E225 - E225
  • [45] PD-1 Haplotype Combinations and Susceptibility of Patients to Squamous Cell Carcinomas of Head and Neck
    Fathi, Farshid
    Faghih, Zahra
    Khademi, Bijan
    Kayedi, Toomaj
    Erfani, Nasrollah
    Gahderi, Abbas
    IMMUNOLOGICAL INVESTIGATIONS, 2019, 48 (01) : 1 - 10
  • [46] Impact of antibiotics on PD-1 inhibition in recurrent/metastatic head and neck squamous cell carcinoma
    Rabjerg, Helene Knap
    Eriksen, Jesper Grau
    Soby, Sebastian
    ORAL ONCOLOGY, 2024, 158
  • [47] PHASE 2 STUDY OF NIVOLUMAB (ANTI-PROGRAMMED DEATH-1 [PD-1]) IN PATIENTS (PTS) WITH ADVANCED, REFRACTORY SQUAMOUS (SQ) NON-SMALL CELL LUNG CANCER (NSCLC)
    Zalcman, G.
    Rizvi, N. A.
    Lena, H.
    Wolf, J.
    Mazieres, J.
    Antonia, S. J.
    Minenza, E.
    Planchard, D.
    Lestini, B. J.
    Ramalingam, S. S.
    ANNALS OF ONCOLOGY, 2015, 26
  • [48] Evaluation of radiomics as a predictor of efficacy and the tumor immune microenvironment in anti-PD-1 mAb treated recurrent/metastatic squamous cell carcinoma of the head and neck patients
    Zandberg, Dan P.
    Zenkin, Serafettin
    Ak, Murat
    Mamindla, Priyadarshini
    Peddagangireddy, Vishal
    Hsieh, Ronan
    Anderson, Jennifer L.
    Delgoffe, Greg M.
    Menk, Ashely
    Skinner, Heath D.
    Duvvuri, Umamaheswar
    Ferris, Robert L.
    Colen, Rivka R.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2025, 47 (01): : 129 - 138
  • [49] PES1 is a biomarker of head and neck squamous cell carcinoma and is associated with the tumor microenvironment
    He, Yaodong
    Xiang, Junwei
    Li, Yunshan
    Huang, Wenkai
    Gu, Feihan
    Wang, Yuanyin
    Chen, Ran
    CANCER MEDICINE, 2023, 12 (11): : 12622 - 12638